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Microcystins are a chemically diverse family of cyclic peptide toxins produced by cyanobacteria. Fewer et al.
show that the production of O-acetylated microcystins is catalyzed by an O-acetyltransferase, McyL. Interest-
ingly, McyL belongs to a family of enzymes that inactivate antibiotics through O-acetylation.Tandem Oxygenations of MaMaking of the Asperlicins
PAGE 870
Asperlicins are alkaloid natural products produced from a fungus.
Gao et al. analyzed the function of a nonribosomal peptide synthase
involved in asperlicins biosynthesis, AspA, and show that it functions
in iterative fashion to transform simple building blocks into the com-
plex structures seen in asperlicins.numycin-type Metabolites
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Epoxyquinone moiety is crucial for various biological functions in number of natural products. Rui et al. reveal a
unique mechanism of tandem oxygenations underlying the biosynthesis of epoxyquinone moiety in manumycin
metabolites and provide evidence for epoxyquinone moiety’s critical role in the anti-MRSA activity.Proapoptotic Activity of PUMA
PAGE 888
PUMA is a BCL-2 family protein that mediates a host of apoptotic responses.
Edwards et al. show that the PUMA death domain, in the form of hydrocar-
bon-stapled PUMA BH3 helices, directly engages BAX to initiate its
functional activation. Thus, PUMA BH3 is a dual antiapoptotic inhibitor and
proapoptotic activator.Quorum Sensing under Proteomic Interrogation
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Lowery et al. use an inhibitor of bacterial communication to monitor changes in the proteome of a pathogen with
the aim of discovering new processes regulated by AI-2-based quorum sensing (QS). The QS antagonists are
valuable tools to confirm proposed and to elucidate previously unidentified QS pathways.Chemistry & Biology 20, July 25, 2013 ª2013 Elsevier Ltd All rights reserved v
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Apilimod is a small molecular inhibitor of IL-12/23 production. Cai et al. show that PIKfyve is the molecular and
therapeutic target of apilimod. Apilimod is a potent yet selective PIKfyve kinase inhibitor. Pharmacological and
genetic studies demonstrate PIKfyve is required for TLR-induced production of IL12/23.mRNA Display Selec
vi Chemistry & Biology 20, July 25,Aging and the Cartilage
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Aging takes a toll on all. Scharf et al. use redox proteomic analysis and MS/MS
mapping to demonstrate several oxidative posttranslational modifications in struc-
tural proteins of intervertebral discs and to determine how protein modifications
contribute to one common aspect of aging: cartilage degeneration.tion of an FK506-Binding Protein
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Tokunaga et al. identify spartin as an FK506-binding protein. FK506 inhibits interaction of spartin with lipid drop-
lets-associated protein, TIP47; blocks localization of spartin and its binder, an E3 ubiquitin ligase, AIP4, in lipid
droplets; and increases protein level of ADRP, a regulator of lipid homeostasis.Multiple Agents May be Needed for Full CFTR Correction
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VX-809 is a small molecule that rescues function of the major cystic fibrosis-causing mutation F508del CFTR,
currently in clinical trial. Farinha et al. assess the additivity and synergy of VX-809 with other rescuing strategies
and provide support for the requirement of combined therapies to fully rescue F508del-CFTR.Resources: From Stem Cells to Alzheimer’s Drugs
PAGE 956
Preclinical models for Alzheimer’s and other neurodegenerative diseases are in
critical demand. McIntire et al. describe a mouse embryonic stem cell-derived
neuronal model that recapitulates physiological properties of AD neuron popula-
tion, bridging the gap between in vitro screening and translational drug discovery.2013 ª2013 Elsevier Ltd All rights reserved
